Human medicines European public assessment report (EPAR): Frehemgo, denecimig, Status: Opinion
Human medicines European public assessment report (EPAR): Inijaq, tofacitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Lifyorli, relacorilant, Status: Opinion
Human medicines European public assessment report (EPAR): Pebrilzo, pertuzumab, Status: Opinion
Human medicines European public assessment report (EPAR): Povofortay, povorcitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Ruxolitinib Zentiva, ruxolitinib, Status: Opinion
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
Summary of opinion: Anzupgo, 17/09/2026 Positive
Human medicines European public assessment report (EPAR): Zeydovio, glepaglutide, Status: Opinion
Summary of opinion: Cosentyx Positive